Attaway Amy, Hatipoğlu Umur
Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic
Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic.
Cleve Clin J Med. 2020 Jul 17. doi: 10.3949/ccjm.87a.ccc007.
Patients with COPD have an increased risk for severe COVID-19. Symptoms such as high-grade fever, anorexia, and myalgia may distinguish COVID-19 from dyspnea due to a COPD-related exacerbation. Management of COVID-19 in the patient with COPD may still warrant standard-of-care exacerbation treatment with antimicrobial agents and corticosteroids. Modalities to treat acute respiratory failure can be used with some caveats. Patients with COPD and COVID-19 infection who treat their illness at home should self-isolate, use nebulizers with precautions to avoid viral aerosolization, and frequently disinfect room surfaces.
慢性阻塞性肺疾病（COPD）患者发生重症新型冠状病毒肺炎（COVID-19）的风险增加。高热、厌食和肌痛等症状可能有助于区分COVID-19与COPD相关加重所致的呼吸困难。COPD患者的COVID-19管理可能仍需采用抗菌药物和皮质类固醇进行标准的加重期治疗。治疗急性呼吸衰竭的方法使用时需注意一些事项。COPD合并COVID-19感染且在家治疗的患者应自我隔离，使用雾化器时要采取预防措施以避免病毒气溶胶化，并经常对房间表面进行消毒。
